ARTICLE | Clinical News
Alora estradiol transdermal system regulatory update
April 15, 2002 7:00 AM UTC
The FDA granted WPI marketing approval for Alora to prevent postmenopausal osteoporosis. Alora already is marketed to treat moderate-to-severe vasomotor symptoms associated with menopause. ...